Updated results of local control and first analysis of survival from the randomised trial of risk-adapted TARGeted Intraoperative radioTherapy (TARGIT-A) for early breast cancer

Authors

J S. Vaidya
F Wenz
Max Bulsara, University of Notre Dame AustraliaFollow
J S. Tobias
D Joseph
M Keshtgar
H Flyger
S Massarut
M Alvarado
C Saunders
W Eiermann
M Metaxas
E Sperk
M Sutterlin
D Brown
L Esserman
M Roncadin
A Thompson
J A. Dewar
H Holtveg
S Pigorsch
M Falzon
E Harris
A Matthews
C Brew-Graves
I Potyka
T Corica
N R. Williams
M Baum

Publication Details

Vaidya, J. S., Wenz, F., Bulsara, M., Tobias, J. S., Joseph, D., Keshtgar, M., Flyger, H., Massarut, S., Alvarado, M., Saunders, C., Eiermann, W., Metaxas, M., Sperk, E., Sutterlin, M., Brown, D., Esserman, L., Roncadin, M., Thompson, A., Dewar, J. A., Holtveg, H., Pigorsch, S., Falzon, M., Harris, E., Matthews, A., Brew-Graves, C., Potyka, I., Corica, T., Williams, N. R., & Baum, M. (2013). Updated results of local control and first analysis of survival from the randomised trial of risk-adapted TARGeted Intraoperative radioTherapy (TARGIT-A) for early breast cancer. Lancet, In press.

Keywords

TARGIT-A, breast cancer